Clinical Trials
The James Cancer Center Columbus, OHopen for enrollment
Ph I/II Nivolumab in comb w/ Lenalidomide in relapsed/refractory NHL and HD
Protocol: OSU-16167
Full Title
A Phase I/II Study of the PD-1 Antibody Nivolumab in combination with Lenalidomide in relapsed/refractory Non-Hodgkins Lymphoma (NHL) and Hodgkins Disease (HD)
For More Information
See Full Trial at ClinicalTrials.gov